|
US6207665B1
(en)
|
1997-06-12 |
2001-03-27 |
Schering Aktiengesellschaft |
Piperazine derivatives and their use as anti-inflammatory agents
|
|
JP2000273087A
(ja)
|
1999-03-24 |
2000-10-03 |
Mitsui Chemicals Inc |
非対称２−イミダゾリジノン類の製造方法
|
|
JP4486817B2
(ja)
|
2001-12-20 |
2010-06-23 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
１，４−ジヒドロ−１，４−ジフェニルピリジン誘導体
|
|
US7385076B2
(en)
|
2002-05-31 |
2008-06-10 |
Sun Pharmaceutical Industries Limited |
Process for the preparation of phenylcarbamates
|
|
GB0219896D0
(en)
|
2002-08-27 |
2002-10-02 |
Bayer Ag |
Dihydropyridine derivatives
|
|
ES2293077T3
(es)
|
2002-08-27 |
2008-03-16 |
Bayer Healthcare Ag |
Derivados de dihidropiridinona como inhbidores de hne.
|
|
US7566723B2
(en)
|
2002-09-10 |
2009-07-28 |
Bayer Healthcare Ag |
1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
|
|
GB2392910A
(en)
|
2002-09-10 |
2004-03-17 |
Bayer Ag |
2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors
|
|
MXPA05002644A
(es)
|
2002-09-10 |
2005-09-20 |
Bayer Healthcare Ag |
Derivados de pirimidinona como agentes terapeuticos contra procesos de remodelacion, isquemicos e inflamatorios agudos y cronicos.
|
|
SE0302324D0
(sv)
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
|
CA2557272C
(en)
|
2004-02-26 |
2012-09-11 |
Bayer Healthcare Ag |
Heterocyclic derivatives
|
|
US8101615B2
(en)
|
2004-02-26 |
2012-01-24 |
Bayer Pharma Aktiengesellschaft |
1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
|
|
PL201306B1
(pl)
|
2004-07-28 |
2009-03-31 |
Politechnika Wroclawska |
Sposób wytwarzania N,N'-alkilidenobis(karbaminianów) dialkilowych
|
|
GB0502258D0
(en)
|
2005-02-03 |
2005-03-09 |
Argenta Discovery Ltd |
Compounds and their use
|
|
DE102005028845A1
(de)
|
2005-06-22 |
2006-12-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
|
|
GB0512940D0
(en)
|
2005-06-24 |
2005-08-03 |
Argenta Discovery Ltd |
Compounds and their use
|
|
EP1937629A2
(en)
|
2005-10-20 |
2008-07-02 |
Sumitomo Chemical Company, Limited |
Benzoylurea compounds and use thereof
|
|
US8198288B2
(en)
|
2006-05-04 |
2012-06-12 |
Pulmagen Therapeutics (Inflammation) Limited |
Tetrahydropyrrolopyrimidinediones and their use in therapy
|
|
MX2008013996A
(es)
|
2006-05-04 |
2009-01-14 |
Argenta Discovery Ltd |
Tetrahidropirrolopirimidindionas y su uso como inhibidores de elastasa de neutrofilo humano.
|
|
WO2009013444A1
(en)
|
2007-07-25 |
2009-01-29 |
Argenta Discovery Limited |
Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
|
|
GB0610765D0
(en)
|
2006-05-31 |
2006-07-12 |
Proskelia Sas |
Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
|
|
DE102006031314A1
(de)
|
2006-07-01 |
2008-01-03 |
Bayer Healthcare Aktiengesellschaft |
Verwendung von 1,4-Diaryl-dihydropyrimidin-2-on-Derivaten zur Behandlung der pulmonalen arteriellen Hyptertonie
|
|
US20100010024A1
(en)
|
2006-07-01 |
2010-01-14 |
Bayer Healthcare Ag |
Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension
|
|
CN101225083A
(zh)
*
|
2007-01-16 |
2008-07-23 |
北京摩力克科技有限公司 |
四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
|
|
WO2009037413A1
(en)
|
2007-09-19 |
2009-03-26 |
Argenta Discovery Limited |
Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases
|
|
WO2009060158A1
(en)
|
2007-11-07 |
2009-05-14 |
Argenta Discovery Limited |
4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrimidine-2, 5-dione derivatives and their use as human neutrophil elastase inhibitors
|
|
WO2009060206A1
(en)
|
2007-11-07 |
2009-05-14 |
Argenta Discovery Limited |
3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
|
|
GB0721866D0
(en)
|
2007-11-07 |
2007-12-19 |
Argenta Discovery Ltd |
Pharmaceutical compounds having dual activities
|
|
DE102008052013A1
(de)
|
2008-10-17 |
2010-04-22 |
Bayer Schering Pharma Aktiengesellschaft |
4-(4-Cyano-2-thioaryl)-dihydropyrimidinone und ihre Verwendung
|
|
DE102008022521A1
(de)
|
2008-05-07 |
2009-11-12 |
Bayer Schering Pharma Aktiengesellschaft |
1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
|
|
HRP20120457T1
(hr)
|
2007-12-20 |
2012-06-30 |
Bayer Pharma Aktiengesellschaft |
4-(4-cijano-2-tioaril)dihidropirimidinoni i njihova uporaba
|
|
DE102007061766A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
4-(4-Cyano-2-thioaryl)-dihydropyrimidinone und ihre Verwendung
|
|
DE102009004197A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung
|
|
DE102009016553A1
(de)
|
2009-04-06 |
2010-10-07 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung
|
|
US8865704B2
(en)
|
2009-10-07 |
2014-10-21 |
Siena Biotech S.P.A. |
Wnt pathway antagonists
|
|
AU2011204277B2
(en)
|
2010-01-08 |
2015-12-24 |
Catabasis Pharmaceuticals, Inc. |
Fatty Acid Fumarate Derivatives and their uses
|
|
WO2011094953A1
(en)
|
2010-02-08 |
2011-08-11 |
F. Hoffmann-La Roche Ag |
Compounds for the treatment and prevention of influenza
|
|
GB201004178D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
JP2013177318A
(ja)
|
2010-06-30 |
2013-09-09 |
Dainippon Sumitomo Pharma Co Ltd |
ジヒドロピリミジノン誘導体およびその医薬用途
|
|
KR20140062476A
(ko)
|
2011-08-01 |
2014-05-23 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
우라실 유도체 및 그 의약 용도
|
|
KR20140060513A
(ko)
|
2011-09-14 |
2014-05-20 |
키에시 파르마슈티시 엣스. 피. 에이. |
인체 호중구 엘라스타제 억제제인 테트라히드로트리아졸로피리미딘 유도체
|